Biotech startup lands $2.5M in new venture capital, prepares for testing

Story excerpt provided by Dayton Business Journal.

Written by Tristan Navera.

A biotech startup has landed new space, $2.5 million in new capital and is preparing a major clinical trial as it sets up to hit the market this year.

Ischemia Care, founded several years ago in Cincinnati, is lining up its final clinical trial for 1,000 patients, which it hopes to get off the ground in the second quarter of this year. This as founder and CEO Jeff June says he hopes its product — a blood test for timely diagnosis and treatment of strokes — could hit the market as soon as this year.

Click here to read the complete article.

Originally published May 9, 2017.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: